INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355 | -15.7% | 14,048 | -29.6% | 0.03% | -18.2% |
| Q2 2023 | $421 | +15.0% | 19,953 | -7.1% | 0.03% | +22.2% |
| Q1 2023 | $366 | -19.9% | 21,479 | -6.2% | 0.03% | -28.9% |
| Q4 2022 | $457 | -99.9% | 22,897 | +19.3% | 0.04% | 0.0% |
| Q3 2022 | $413,000 | -0.2% | 19,185 | -8.7% | 0.04% | +2.7% |
| Q2 2022 | $414,000 | +45.3% | 21,006 | +73.4% | 0.04% | +311.1% |
| Q1 2022 | $285,000 | – | 12,116 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |